FDA Warning Letters about Food Products

How to Avoid or Respond to Citations
Erscheinungsjahr 2017
ISBN: 978-0-12-805470-3
Verlag: Elsevier Science

Buch, Englisch, 334 Seiten, Format (B × H): 242 mm x 199 mm, Gewicht: 860 g

FDA Warning Letters About Food Products: How to Avoid or Respond to Citations uses examples of FDA warning letters about food products as training tools to discuss important quality and manufacturing issues encountered by food companies around the world as they bring food products into the US market.

Focused specifically on FDA warning letters surrounding new dietary ingredients and dietary supplements, the book first introduces FDA warning letters in general. Each chapter then focuses on specific issues identified, including HAACP/quality systems, imports/exports, food contact issues, etc.

This book helps the food industry train professional team members (across the spectrum of experience levels) to avoid common issues often cited in warning letters. It serves both as an authoritative reference on the common types of warning letters issued to food companies today, and as a guide to best practices for food manufacturers.

Autoren/Hrsg.

Frestedt, Joy

Fachgebiete

• Rechtswissenschaften Ausländisches Recht Common Law (UK, USA, Australien u.a.)
• Geowissenschaften Umweltwissenschaften Lebensmittelsicherheit und -versorgung
• Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Primärer Sektor Agrarökonomie, Ernährungswirtschaft

Inhaltsverzeichnis

1. History of Warning Letters to Food Companies2. Introduction to Quality Systems3. HAACP4. Imports/Exports5. Food Contact Products6. Clinical Trials for Foods and Dietary Supplements7. Food Safety Modernization Act8. Future Trends and Directions

Über Autor(innen)

Frestedt, Joy
Joy Frestedt Is the President and CEO for Frestedt Incorporated, a consulting group of over 70 experts providing services in broad CRQE areas of clinical trial development and execution, as well as US and international regulatory compliance, management of corporate quality systems, and biomedical engineering. She has managed clinical research, regulatory affairs, and quality systems for more than 40 years and has published more than 100 manuscripts, as well as book chapters. With a PhD in Pathobiology from the University of Minnesota Medical School, her experience includes designing, conducting and overseeing clinical trials as well as negotiating regulatory submissions and developing quality systems for companies like the University of Minnesota, Orphan Medical, Astra Zeneca Pharmaceuticals, Johnson and Johnson, Medtronic, and Mayo Clinical Trial Services.